XML 48 R5.htm IDEA: XBRL DOCUMENT v3.20.1
Condensed Consolidated Statements Of Stockholders' Equity - USD ($)
$ in Thousands
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Total
Balance at Dec. 30, 2017 $ 80 $ 152,640 $ (158,046) $ (5,326)
Balance, shares at Dec. 30, 2017 79,314,000      
Stock-based compensation   737   737
Exercise of stock options   11   11
Exercise of stock options, shares 30,000      
Issuance of restricted stock, shares 525,000      
Issuance of common stock, net $ 59 15,703   $ 15,762
Issuance of common stock, shares 59,414,000     31,786,146
Warrants issued in lieu of payments   74   $ 74
Estimated fair value of conversion option, in connection with convertible debt   190   190
Net loss     (17,120) (17,120)
Balance at Dec. 29, 2018 $ 139 169,355 (175,166) (5,672)
Balance, shares at Dec. 29, 2018 139,283,000      
Stock-based compensation   989   989
Exercise of stock options   49   $ 49
Exercise of stock options, shares 175,000     175,000
Issuance of restricted stock $ 1 (1)    
Issuance of restricted stock, shares 749,000      
Tax withholdings related to net share settlements of equity awards   (77)   $ (77)
Tax withholdings related to net share settlements of equity awards (in shares) (222,000)      
Issuance of common stock, net, and commitment shares $ 20 6,332   6,352
Issuance of common stock, net, and commitment shares (in shares) 20,387,000      
Common stock issued on conversion of Iliad Note $ 9 2,439   2,448
Common stock issued on conversion of Iliad Note (in shares) 9,167,000      
Net loss     (12,452) (12,452)
Balance at Dec. 28, 2019 $ 169 $ 179,086 $ (187,618) $ (8,363)
Balance, shares at Dec. 28, 2019 169,539,000